Candidate early predictive plasma protein markers of doxorubicin-induced chronic cardiotoxicity in B6C3F(1) mice
- Authors
- Desai, Varsha G.; Lee, Taewon; Moland, Carrie L.; Vijay, Vikrant; Han, Tao; Lewis, Sherry M.; Herman, Eugene H.; Fuscoe, James C.
- Issue Date
- 15-Jan-2019
- Publisher
- ACADEMIC PRESS INC ELSEVIER SCIENCE
- Keywords
- Cardiotoxicity; Doxorubicin; Dexrazoxane; Mouse Plasma; Biomarkers; SOMAscan (TM) Proteomic Assay
- Citation
- TOXICOLOGY AND APPLIED PHARMACOLOGY, v.363, pp 164 - 173
- Pages
- 10
- Indexed
- SCI
SCIE
SCOPUS
- Journal Title
- TOXICOLOGY AND APPLIED PHARMACOLOGY
- Volume
- 363
- Start Page
- 164
- End Page
- 173
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/68289
- DOI
- 10.1016/j.taap.2018.11.016
- ISSN
- 0041-008X
1096-0333
- Abstract
- Cardiotoxicity is a serious adverse effect of doxorubicin (DOX) treatment in cancer patients. Currently, there is a lack of sensitive biomarkers to predict the risk of DOX-induced cardiotoxicity. Using SOMAmer-based proteomic technology, 1129 proteins were profiled to identify potential early biomarkers of cardiotoxicity in plasma from male B6C3F(1) mice given a weekly intravenous dose of 3 mg/kg DOX or saline (SAL) for 2, 3, 4, 6, or 8 weeks (6, 9, 12, 18, or 24 mg/kg cumulative DOX doses, respectively). Also, a group of mice received the cardio-protectant, dexrazoxane (DXZ; 60 mg/kg; intraperitoneal) 30 min before a weekly DOX or SAL dose. Proteomic analysis in plasma collected a week after the last dose showed a significant >= 1.2-fold change in level of 18 proteins in DOX-treated mice compared to SAL-treated counterparts during 8-week exposure. Of these, neurogenic locus notch homolog protein 1 (NOTCH1), von Willebrand factor (vWF), mitochondria) glutamate carrier 2, Wnt inhibitory factor 1, legumain, and mannan-binding lectin serine protease 1 were increased in plasma at 6 mg/kg cumulative DOX dose, prior to the release of myocardial injury marker, cardiac troponin I at 12 mg/kg and higher cumulative doses. These six proteins also remained significantly elevated following myocardial injury or pathology at 24 mg/kg. Pretreatment of mice with DXZ significantly attenuated DOX-induced elevated levels of only NOTCH1 and vWF with mitigation of cardiotoxicity. This suggests NOTCH1 and vWF as candidate early biomarkers of DOX cardiotoxicity, which may help in addressing a clinically important question of identifying cancer patients at risk for cardiotoxicity.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Applied Mathematics > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.